; (B) the goals specified in such application, as required by subsection (a)(1); or (C) the reasoning described in subsection (c); and (2) ensure that, in publishing information relating to an application under paragraph (1), the design of the study involved is not disclosed. (e) Remediation (1) In general In the case of a clinical trial subject to subsection (a) that fails to meet the condition specified pursuant to subsection (a) by such date as may be agreed upon by the sponsor of the trial and the program officer and grants management specialist of the specific National Institutes of Health national research institute or national center, the Secretary shall require the sponsor of that clinical trial, not later than 90 days after such date occurs— (A) to develop, in consultation with the Secretary and advocacy and community-based organizations representing individuals who are members of relevant demographic groups specified in subsection (a)(1), a strategic plan to increase participation in such clinical trial of such individuals